54
Participants
Start Date
June 1, 2017
Primary Completion Date
October 15, 2018
Study Completion Date
October 31, 2018
diacerein 1% ointment
diacerein 1% ointment administered topically
A placebo ointment
vehicle ointment administered topically
Premier Specialists Pty Ltd; The Church, Kogarah
Stony Brook University Medical Center, Stony Brook
University of North Carolina - Chapel Hill, Chapel Hill
Cincinnati Children's Hospital Medical Center, Cincinnati
University of Minnesota, Minneapolis
Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Northwestern University, Chicago
University of Missouri Healthcare, Columbia
Hopital Saint Louis, Paris
Hopital Necker-Enfants Malades, Paris
Children's Hospital of San Antonio ; Texas Dermatology and Laser Specialists, San Antonio
University Medical Center Freiburg, Freiburg im Breisgau
Children's Hospital Colorado, Aurora
Phoenix Childrens Hospital, Phoenix
Stanford University, Palo Alto
Tel Aviv Sourasky Medical Center, Tel Aviv
Medical University of South Carolina (MUSC), Charleston
EB House Austria, Salzburg
CHU de NICE - Hopital de l'Archet II - Service de Dermatologie, Nice
University Medical Center Groningen, Groningen
Great Ormond Street Hospital, London
St. Thomas' Hospital - St Johns Institute of Dermatology, London
Lead Sponsor
Castle Creek Pharmaceuticals, LLC
INDUSTRY